[Human immunodeficiency virus infections and hospital structures: trends in the Public Assistance of Paris] NLM AIDSLINE Important note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Human immunodeficiency virus infections and hospital structures: trends in the Public Assistance of Paris]

Ann Med Interne (Paris). 1988;139(7):508-10. Unique Identifier : AIDSLINE MED/89226753
Chevallier J; Vidal-Trecan G; Service d'Epidemiologie, Assistance publique-Hopitaux de Paris.

Abstract: The evolution of the number of patients with the AIDS virus admitted to the Paris hospitals is monitored by two index systems, one based on the discharge diagnosis and the other a transverse inquiry on a given day, updated every three months since its conception at the beginning of 1986. This index also allows an evaluation of the number of patients consulting for this condition. In 1986, AIDS and AIDS related complexes (ARC) represented 1 p. 100 of the activity of the Assistance Publique Paris hospitals including all in- and outpatients. These conditions will probably account for 2 p. 100 of the activity in 1987. The duration of cumulated hospital stay is on average 30 days per year for AIDS and ARC, divided into roughly 3 admissions, with a tendency towards more under-24 hour stays and domiciliary care. The clinical departments looking after these patients are varied and increasing in number, but most of the work is carried out by Departments of Infectious and Parasitic Medicine.
Keywords: *Acquired Immunodeficiency Syndrome/EPIDEMIOLOGY AIDS-Related Complex/EPIDEMIOLOGY Carrier State/EPIDEMIOLOGY English Abstract *Hospitalization/ECONOMICS/TRENDS Human Paris *Public Assistance JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/epidemiologyaids-relatedcomplex/epidemiologycarrierstate/epidemiologyenglishabstractKWDhospitalization/economics/trendshumanparisKWDpublicassistancejournalarticle
890830
M8980764

Copyright © 1989 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1989. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1989. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .